The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System
Open accessAbstract
BackgroundThe first consensus Merkel cell carcinoma (MCC) staging system was published in 2010. New information on the clinical course prompts review of MCC staging.MethodsA total of 9387 MCC cases from the National Cancer Data Base Participant User File with follow-up and staging data (1998–2012) were analyzed. Prognostic differences based on clinical and pathological staging were evaluated. Survival estimates were compared by disease extent.ResultsSixty-five percent of cases presented with local disease, whereas 26 and 8 % presented with nodal and distant disease. Disease extent at presentation was predictive of 5-year overall survival (OS) with estimates of 51, 35, and 14 % for local, nodal, and distant disease. Tumor burden at the regional nodal basin was predictive of 5-year OS with estimates of 40 and 27 % for clinically occult and clinically detected nodal disease. For local disease, we confirm improved prognosis when the regional nodal basin was negative by pathological compared with clinical staging. We identified 336 cases with clinically detected nodal disease and unknown primary tumor and showed improved prognosis over cases presenting with concurrent primary tumor (OS estimates of 42 vs. 27 %).ConclusionsAnalysis of a national dataset of MCC cases validates the predictive value of disease extent at presentation. Separation of clinical and pathological stage groups and regrouping of unknown primary tumors are supported by the analysis. The revised staging system provides more accurate prognostication and has been formally accepted by the AJCC staging committee for inclusion in the 8th edition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,853
The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States
Bilimoria, K. Y., Stewart, A. K., Winchester, D. P., & Ko, C. Y. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9747-3 · Cited by 1,851
American Joint Committee on Cancer (2010) · Springer eBooks · doi:10.1007/978-0-387-88441-7 · Cited by 1,328
Lemos, B. D., Storer, B. E., Iyer, J. G., Phillips, J. L., Bichakjian, C. K., Fang, L. C., Johnson, T. M., Liegeois-Kwon, N. J., Otley, C. C., Paulson, K. G., et al. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.02.056 · Cited by 559
Self-citationPrognostic factors in Merkel cell carcinoma: Analysis of 240 cases
Tarantola, T. I., Vallow, L. A., Halyard, M. Y., Weenig, R. H., Warschaw, K. E., Grotz, T. E., Jakub, J. W., Roenigk, R. K., Brewer, J. D., Weaver, A. L., et al. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.09.036 · Cited by 179
Five Hundred Patients With Merkel Cell Carcinoma Evaluated at a Single Institution
Fields, R. C., Busam, K. J., Chou, J. F., Panageas, K. S., Pulitzer, M. P., Allen, P. J., Kraus, D. H., Brady, M. S., & Coit, D. G. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e31822c5fc1 · Cited by 166
Sentinel Lymph Node Biopsy is Associated with Improved Survival in Merkel Cell Carcinoma
Kachare, S. D., Wong, J. H., Vohra, N. A., Zervos, E. E., & Fitzgerald, T. L. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3434-3 · Cited by 81
Foote, M. C., Veness, M., Zarate, D., & Poulsen, M. G. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.09.009 · Cited by 80
Unknown primary Merkel cell carcinoma: 23 new cases and a review
Tarantola, T. I., Vallow, L. A., Halyard, M. Y., Weenig, R. H., Warschaw, K. E., Weaver, A. L., Roenigk, R. K., Brewer, J. D., & Otley, C. C. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.07.035 · Cited by 73
Cited by
Nghiem, P., Bhatia, S., Lipson, E. J., Sharfman, W. H., Kudchadkar, R. R., Brohl, A. S., Friedlander, P. A., Daud, A., Kluger, H. M., Reddy, S. A., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01896 · Cited by 396
Self-citationMerkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology
Bichakjian, C. K., Olencki, T., Aasi, S. Z., Alam, M., Andersen, J. S., Blitzblau, R., Bowen, G. M., Contreras, C. M., Daniels, G. A., Decker, R., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0055 · Cited by 319
Self-citationThe biology and treatment of Merkel cell carcinoma: current understanding and research priorities
on behalf of the International Workshop on Merkel Cell Carcinoma Research (IWMCC) Working Group, Harms, P. W., Harms, K. L., Moore, P. S., DeCaprio, J. A., Nghiem, P., Wong, M. K. K., & Brownell, I. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0103-2 · Cited by 316
Self-citationNeoadjuvant nivolumab for patients with resectable merkel cell carcinoma in the CheckMate 358 trial
Topalian, S. L., Bhatia, S., Amin, A., Kudchadkar, R. R., Sharfman, W. H., Lebbé, C., Delord, J.-P., Dunn, L. A., Shinohara, M. M., Kulikauskas, R., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00201 · Cited by 280
Self-citationJenkins, B. A., & Lumpkin, E. A. (2017) · Development · doi:10.1242/dev.120402 · Cited by 79
Metadata
- Authors
- Harms, K. L., Healy, M. A., Nghiem, P., Sober, A. J., Johnson, T. M., Bichakjian, C. K., & Wong, S. L.
- Venue
- Annals of Surgical Oncology
- Published
- 2016-05-19
- Volume
- 23
- Issue
- 11
- Pages
- 3564-3571
- ISSN
- 1068-9265 (ISSN-L)
- 1534-4681
- OpenAlex
- W2407443857
- Cited by
- 558
- References
- 14
- FWCI
- 21.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System. https://app.cochat.ai/papers/10.1245/s10434-016-5266-4
- The paper
- Harms, K. L., Healy, M. A., Nghiem, P., Sober, A. J., Johnson, T. M., Bichakjian, C. K., & Wong, S. L. (2016). Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-016-5266-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.